{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:47:20Z","timestamp":1782532040419,"version":"3.54.5"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7389-26","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:12:49Z","timestamp":1782511969000},"source":"Crossref","is-referenced-by-count":0,"title":["A Marked Improvement in Mild but Progressive Autoimmune Pulmonary Alveolar Proteinosis Treated with Inhaled Granulocyte-Macrophage Colony-Stimulating Factor Therapy: A Case Report"],"prefix":"10.2169","author":[{"given":"Takeshi","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Suga","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Iri","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fujiki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 349: 2527-2539, 2003.","DOI":"10.1056\/NEJMra023226"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Campo I, Luisetti M, Griese M, et al. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. Orphanet J Rare Dis 11: 115, 2016.","DOI":"10.1186\/s13023-016-0497-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166: 215-235, 2002.","DOI":"10.1164\/rccm.2109105"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. N Engl J Med 381: 923-932, 2019.","DOI":"10.1056\/NEJMoa1816216"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Trapnell BC, Inoue Y, Bonella F, et al. Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis. N Engl J Med 383: 1635-1644, 2020.","DOI":"10.1056\/NEJMoa1913590"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Trapnell BC, Inoue Y, Bonella F, et al. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. N Engl J Med 393: 764-773, 2025.","DOI":"10.1056\/NEJMoa2410542"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Tazawa R, Nakata K. A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis. Respirology 30: 463-465, 2025.","DOI":"10.1111\/resp.70048"},{"key":"8","unstructured":"8. The JRS Clinical Practice Guideline for Pulmonary Alveolar Proteinosis, 2022 edition [Internet]. [cited 2026 Feb 13]. Available from: https:\/\/www.jrs.or.jp\/publication\/file\/pap2022_241009.pdf.."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177: 752-762, 2008.","DOI":"10.1164\/rccm.200708-1271OC"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte\/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 181: 1345-1354, 2010.","DOI":"10.1164\/rccm.200906-0978OC"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wylam ME, Ten R, Prakash UB, Nadrous HF, Clawson ML, Anderson PM. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 27: 585-593, 2006.","DOI":"10.1183\/09031936.06.00058305"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ohkouchi S, Akasaka K, Ichiwata T, et al. Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases. Ann Am Thorac Soc 14: 1298-1304, 2017.","DOI":"10.1513\/AnnalsATS.201611-892BC"},{"key":"13","unstructured":"13. Ding J, Xiao Y, Dai J, et al. [Effectiveness and safety of inhaled granulocyte-macrophage colony-stimulating factor therapy in idiopathic pulmonary alveolar proteinosis]. Zhonghua Yi Xue Za Zhi 95: 2766-2770, 2015."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Campo I, Carey BC, Paracchini E, et al. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients. Eur Respir J 63: \u2605, 2024.","DOI":"10.1183\/13993003.congress-2024.OA1059"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tian X, Yang Y, Chen L, et al. Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up. Orphanet J Rare Dis 15: 174, 2020.","DOI":"10.1186\/s13023-020-01450-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Akira M, Inoue Y, Arai T, et al. Pulmonary Fibrosis on High-Resolution CT of Patients With Pulmonary Alveolar Proteinosis. AJR Am J Roentgenol 207: 544-551, 2016.","DOI":"10.2214\/AJR.15.14982"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. McCarthy C, Carey BC, Trapnell BC. Autoimmune Pulmonary Alveolar Proteinosis. Am J Respir Crit Care Med 205: 1016-1035, 2022.","DOI":"10.1164\/rccm.202112-2742SO"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chen W, Feng X, Yao LK, et al. Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review. Front Med (Lausanne) 12: 1552566, 2025.","DOI":"10.3389\/fmed.2025.1552566"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Awab A, Khan MS, Youness HA. Whole lung lavage-technical details, challenges and management of complications. J Thorac Dis 9: 1697-1706, 2017.","DOI":"10.21037\/jtd.2017.04.10"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sahoo S, Saxena P, Ravi AK, et al. Spontaneous Resolution in Autoimmune Pulmonary Alveolar Proteinosis: A Case Series. Chest 167: e177-e181, 2025.","DOI":"10.1016\/j.chest.2025.01.030"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7389-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:26:56Z","timestamp":1782530816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7389-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7389-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7389-26"}}